Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BARDA
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BARDA
-
BARDA is soliciting simplified proposals under our streamlined, business friendly EZ-BAA for
#2019nCoV molecular diagnostics, based on@FDA-cleared/approved platforms. Find out how your company can partner with us! https://www.hhs.gov/about/news/2020/02/05/hhs-seeks-abstract-submissions-for-2019-ncov-diagnostics-development.html …pic.twitter.com/lnunpkncsQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re expanding our partnership w/
@Regeneron to use their existing monoclonal antibody discovery platform to develop multiple monoclonal antibodies that, individually or in combination, could be used to develop therapeutics to treat#2019nCoV https://www.hhs.gov/about/news/2020/02/04/hhs-regeneron-collaborate-to-develop-2019-ncov-treatment.html …pic.twitter.com/5IvGwMnJK6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Responding to an influenza pandemic requires more modern, domestically produced vaccines. We're excited to announce AUDENZ, a next-gen pandemic influenza vaccine using antigen-sparing adjuvant & cell-based vaccine technology, has been licensed by
@US_FDA. https://www.phe.gov/ASPRBlog/pages/BlogArticlePage.aspx?PostID=372 …pic.twitter.com/fuxAzVd21l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
BARDA is supporting US government market research to identify medical countermeasures with the potential to help address the
#2019nCoV outbreak. If your company is developing diagnostics, therapeutics, vaccines, or other products, submit your ideas here
https://www.medicalcountermeasures.gov/app/barda/coronavirus.aspx …pic.twitter.com/hf7cfGGy2N
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
As part of the Administration’s work to protect Americans and respond to the 2019 Novel
#Coronavirus outbreak, today I signed a public health emergency declaration.pic.twitter.com/cpQzmgu9VI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA is supporting US government market research to identify medical countermeasures with the potential to help address the
#2019nCoV outbreak. If your company is developing diagnostics, therapeutics, vaccines, or other products, submit your ideas here
https://www.medicalcountermeasures.gov/app/barda/coronavirus.aspx …pic.twitter.com/hf7cfGGy2N
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
Get the latest on issues surrounding the 2019 Novel
#Coronavirus. Register today to join us for a listening session to discuss medical countermeasures challenges and other public health and medical issues related to the current#2019nCoV outbreak. https://www.phe.gov/Preparedness/planning/2019-nCoV/Pages/default.aspx …pic.twitter.com/qtE33C7Dfa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
To help transform
#HealthSecurity, new BARDA DRIVe partner Rizlab Health will leverage its pocket-sized blood count analyzer technology to develop a way to alert users of illness before symptoms occur. Learn more about#DRIVeInnovation and this project: https://bit.ly/2UOmIR8 pic.twitter.com/o96Nu5IXzwHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA DRIVe is partnering with GE Research and Feinstein Institute for Medical Research to improve
#HealthSecurity by leveraging portable ultrasound technology to test whether infection can be detected before symptoms occur. Learn more at https://drive.hhs.gov/news.html#DRIVeInnovationpic.twitter.com/6BBRvaSvXDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
Today, we celebrated the life of Edward J. Gabriel and honored him with the Investor in People Leadership Award. The contributions he made to New York City, to
@HHSGov, and to the protection of his fellow Americans are a source of inspiration for all of us.pic.twitter.com/vmPV8T6lbg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
Deadline approaching! The Invisible Shield
#QuickFireChallenge seeks potential solutions that protect against airborne viruses & integrate into daily life. Apply for the chance to earn up to $200K in funding from@BARDA + mentoring https://hubs.ly/H0lh1YR0 pic.twitter.com/Bl5P1xo3pW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
In cases where patients are infected with antibiotic resistant infections, a rapid diagnosis can save life or limb – and the need for speed skyrockets during a public health emergency. Find out what
@BARDA is doing to support fast, accurate diagnostics. https://www.phe.gov/ASPRBlog/pages/BlogArticlePage.aspx?PostID=369 …pic.twitter.com/HKrWaMDwZ0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Every 11 seconds, someone in the U.S. is infected with drug-resistant bacteria, and current diagnostic tests don’t provide results quickly enough. Find out what BARDA is doing to bring diagnostics closer to the patient & rapidly diagnose infections. https://www.phe.gov/ASPRBlog/pages/BlogArticlePage.aspx?PostID=369 …pic.twitter.com/Ynitox2wjS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When BARDA Director Rick Bright got a minor cut while gardening, he wasn’t expecting it to get infected with MRSA. Find out how that cut & a delayed diagnosis led to the misuse of antibiotics, threatened patient health, increased healthcare costs & more. https://www.phe.gov/ASPRBlog/pages/BlogArticlePage.aspx?PostID=368 …pic.twitter.com/M2Oyc1xQRa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@US_FDA has licensed ERVEBO, the world’s first vaccine to prevent#Ebola disease. At BARDA, we are honored to be part of this unprecedented collaboration between@Merck & other key partners to develop this lifesaving vaccine. https://www.hhs.gov/about/news/2019/12/19/hhs-secretary-azar-statement-on-fda-approval-of-ebola-vaccine.html …pic.twitter.com/BNAB2uZKih
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA is partnering with
@ParatekPharma on the advanced development of an antibiotic to treat anthrax lung infections. NUZYRA is approved to treat community-acquired bacterial pneumonia & acute skin infections, which can complicate disaster response. https://www.hhs.gov/about/news/2019/12/18/hhs-supports-advanced-development-treatment-anthrax-lung-infections.html …pic.twitter.com/HzptAJNqZb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Erika Davies spoke at
#CTTACC about our novel blood product and blood sustainability portfolio. BARDA works with partners to develop next generation blood products to#SaveLives after a#MassCasualty event that could limit the US blood supply. RFI: https://bit.ly/2LSjOEc pic.twitter.com/GcSnwYo9dZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Director Bright is
@JLABS NYC for a discussion on protecting the world’s most#vulnerable populations. Disasters don't discriminate based on age, gender, socio-economics, or health status, so medical countermeasures must be available for all.#innovation#HealthSecuritypic.twitter.com/omZqI0yXA8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BARDA proslijedio/la je Tweet
As part of the administration's efforts
#FightFlu,@BARDA announced a new initiative to increase domestic capacity to manufacture recombinant flu vaccines, which are faster & more flexible than traditional egg-based approaches. https://www.hhs.gov/about/news/2019/12/09/hhs-invests-modernizing-us-manufacturing-capacity-pandemic-influenza-vaccine.html?fbclid=IwAR2O8GcuL-GDApKXFCwnsVHeDif6VbUFpG9Wd_-u74waFELUaiCl3LDmUKM …https://twitter.com/PHEgov/status/1204038925981016065 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The DRIVe team at the 2019 Global Biosensors Summit sharing information on the Early Notification to Act, Control & Treat (ENACT) portfolio. Learn more about the ENACT program here: https://drive.hhs.gov/enact.html pic.twitter.com/iz7nulvgHK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.